Matt Kalaycio, MD, FACP, has been elected as the chair of the National Comprehensive Cancer Network’s board of directors, succeeding John W. Sweetenham, MD, FRCP, FACP, FASCO. Christopher H. Lieu, MD, has been elected as the vice chair. The NCCN aims to provide high-quality, patient-centered cancer care worldwide by offering evidence-based treatment options to healthcare providers and support to patients and caregivers. Kalaycio, a specialist in leukemia and hematopoietic cell transplantation, looks forward to advancing the organization’s mission. Lieu, a specialist in gastrointestinal cancer, is honored to serve as the vice-chair and is excited to work with the NCCN leadership.
Source link
National Comprehensive Cancer Network appoints board of directors chair, vice chair
